Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a

被引:0
作者
M Ticchioni
M Essafi
P Y Jeandel
F Davi
J P Cassuto
M Deckert
A Bernard
机构
[1] Hôpital de l'Archet,Département d'Immunologie
[2] Université de Nice-Sophia Antipolis,Département de Médecine Interne
[3] Inserm,Département d'Hématologie
[4] UMR576,Département d'Hématologie
[5] Hôpital de l'Archet,undefined
[6] Hôpital de l'Archet,undefined
[7] Université de Nice-Sophia Antipolis,undefined
[8] Groupe Hospitalier de la Pitié-Salpétrière,undefined
[9] Université Pierre et Marie Curie,undefined
[10] Hôpital de l'Archet,undefined
[11] Université de Nice-Sophia Antipolis,undefined
来源
Oncogene | 2007年 / 26卷
关键词
B-CLL; chemokines; survival; Akt; FOXO3a;
D O I
暂无
中图分类号
学科分类号
摘要
B-chronic lymphocytic leukemia (B-CLL) cell is characterized by the accumulation of long-lived CD5+ B lymphocytes, whose survival in vivo is in part dependent on exogenous factors such as cytokines and/or extracellular matrix proteins. Homeostatic chemokines are critical mediators of lymphoid cell trafficking. However, how they function in cell signaling and survival remains ill-defined. In this study, we have investigated the role of the homeostatic chemokines, CXCL12, CCL21, CCL19 and CXCL13, in B-CLL cell survival. Using primary leukemic cells isolated from 26 patients, we observed that each chemokine enhances cell survival. Chemokines induced the phosphorylation of ERK1/2 and p90RSK, and of Akt and its effectors GSK3 and FOXO3a. Consistently, inhibitors against mitogen-activated protein kinase/extracellular signal-regulated kinase and phosphatidylinositol 3-kinase inhibited chemokine-induced survival. Moreover, using a constitutively active mutated form of FOXO3a or siRNAs against FOXO3a in transfection experiments performed in primary B-CLL cells, we directly demonstrated the critical role of FOXO3a in both spontaneous and chemokine-induced B-CLL cell survival. Overall, our data support the notion that homeostatic chemokines contribute to B-CLL resistance to cell death through inactivation of the transcription factor FOXO3a, which may represent a novel therapeutic target in this hematopoietic malignancy.
引用
收藏
页码:7081 / 7091
页数:10
相关论文
共 157 条
  • [21] Kipps TJ(2003)Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL) Br J Haematol 121 97-100
  • [22] Burger M(2001)Chemokines as regulators of T cell differentiation Nat Immunol 2 102-107
  • [23] Hartmann T(2000)Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis Blood 96 4142-4151
  • [24] Krome M(2003)Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling J Cell Physiol 195 290-297
  • [25] Rawluk J(2001)Lymphocyte traffic control by chemokines Nat Immunol 2 123-128
  • [26] Tamamura H(1999)Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis Blood 94 853-863
  • [27] Fujii N(2005)Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha Blood 106 1012-1020
  • [28] Burgering BM(2002)Chemokine requirements for B cell entry to lymph nodes and Peyer's patches J Exp Med 196 65-75
  • [29] Medema RH(2003)The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells Blood 101 2454-2460
  • [30] Caligaris-Cappio F(2002)Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta Blood 100 3741-3748